Metabolic glycoengineering : exploring glycosylation with bioorthogonal chemistry

Lade...
Vorschaubild
Dateien
Kufleitner_2-beyjb0inlt5g9.PDF
Kufleitner_2-beyjb0inlt5g9.PDFGröße: 1.47 MBDownloads: 22
Datum
2023
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
oops
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Chemical Society Reviews. Royal Society of Chemistry (RSC). 2023, 52(2), pp. 510-535. ISSN 0306-0012. eISSN 1460-4744. Available under: doi: 10.1039/D2CS00764A
Zusammenfassung

Glycans are involved in numerous biological recognition events. Being secondary gene products, their labeling by genetic methods – comparable to GFP labeling of proteins – is not possible. To overcome this limitation, metabolic glycoengineering (MGE, also known as metabolic oligosaccharide engineering, MOE) has been developed. In this approach, cells or organisms are treated with synthetic carbohydrate derivatives that are modified with a chemical reporter group. In the cytosol, the compounds are metabolized and incorporated into newly synthesized glycoconjugates. Subsequently, the reporter groups can be further derivatized in a bioorthogonal ligation reaction. In this way, glycans can be visualized or isolated. Furthermore, diverse targeting strategies have been developed to direct drugs, nanoparticles, or whole cells to a desired location. This review summarizes research in the field of MGE carried out in recent years. After an introduction to the bioorthogonal ligation reactions that have been used in in connection with MGE, an overview on carbohydrate derivatives for MGE is given. The last part of the review focuses on the many applications of MGE starting from mammalian cells to experiments with animals and other organisms.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
540 Chemie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690KUFLEITNER, Markus, Lisa Maria HAIBER, Valentin WITTMANN, 2023. Metabolic glycoengineering : exploring glycosylation with bioorthogonal chemistry. In: Chemical Society Reviews. Royal Society of Chemistry (RSC). 2023, 52(2), pp. 510-535. ISSN 0306-0012. eISSN 1460-4744. Available under: doi: 10.1039/D2CS00764A
BibTex
@article{Kufleitner2023Metab-59760,
  year={2023},
  doi={10.1039/D2CS00764A},
  title={Metabolic glycoengineering : exploring glycosylation with bioorthogonal chemistry},
  number={2},
  volume={52},
  issn={0306-0012},
  journal={Chemical Society Reviews},
  pages={510--535},
  author={Kufleitner, Markus and Haiber, Lisa Maria and Wittmann, Valentin}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/59760">
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Kufleitner, Markus</dc:creator>
    <dc:language>eng</dc:language>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:contributor>Kufleitner, Markus</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-18T07:27:26Z</dcterms:available>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59760/1/Kufleitner_2-beyjb0inlt5g9.PDF"/>
    <dc:contributor>Wittmann, Valentin</dc:contributor>
    <dc:creator>Haiber, Lisa Maria</dc:creator>
    <dcterms:issued>2023</dcterms:issued>
    <dcterms:title>Metabolic glycoengineering : exploring glycosylation with bioorthogonal chemistry</dcterms:title>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59760/1/Kufleitner_2-beyjb0inlt5g9.PDF"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-18T07:27:26Z</dc:date>
    <dc:creator>Wittmann, Valentin</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/59760"/>
    <dc:contributor>Haiber, Lisa Maria</dc:contributor>
    <dcterms:abstract xml:lang="eng">Glycans are involved in numerous biological recognition events. Being secondary gene products, their labeling by genetic methods – comparable to GFP labeling of proteins – is not possible. To overcome this limitation, metabolic glycoengineering (MGE, also known as metabolic oligosaccharide engineering, MOE) has been developed. In this approach, cells or organisms are treated with synthetic carbohydrate derivatives that are modified with a chemical reporter group. In the cytosol, the compounds are metabolized and incorporated into newly synthesized glycoconjugates. Subsequently, the reporter groups can be further derivatized in a bioorthogonal ligation reaction. In this way, glycans can be visualized or isolated. Furthermore, diverse targeting strategies have been developed to direct drugs, nanoparticles, or whole cells to a desired location. This review summarizes research in the field of MGE carried out in recent years. After an introduction to the bioorthogonal ligation reactions that have been used in in connection with MGE, an overview on carbohydrate derivatives for MGE is given. The last part of the review focuses on the many applications of MGE starting from mammalian cells to experiments with animals and other organisms.</dcterms:abstract>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen